4.6 Article

Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Clinical and survival characteristics of primary and secondary gliosarcoma patients

Ahmad Amer et al.

Summary: Gliosarcoma (GS) is a subtype of glioblastoma with sarcomatous features that has a propensity to metastasize and lower 5-year survival rates. This study compares the survival differences between primary and secondary GS and provides insights into the survival patterns of GS.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Article Pathology

Gliosarcoma with osteosarcomatous component: A case report and short review illustration

Yanming Chen et al.

Summary: We presented a rare case of gliosarcoma (GS) with osteosarcomatous differentiation and lung multi-metastases. Integrated analysis of histopathology, molecular pathology, and genomic alterations provided insights into the natural history and mechanisms of this unusual differentiation of GS into osteosarcoma.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Review Oncology

Primary versus secondary gliosarcoma: a systematic review and meta-analysis

Huy Gia Vuong et al.

Summary: This meta-analysis investigated the clinicopathological features, prognostic survivals, and molecular profiles of primary and secondary gliosarcomas. The results showed that these rare brain tumors have distinct clinicopathological profiles and prognoses but similar genetic profiles.

JOURNAL OF NEURO-ONCOLOGY (2022)

Article Clinical Neurology

Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma

Daniela Pierscianek et al.

Summary: This study analyzed independent outcome predictors of Gliosarcoma (GSC) and found that characteristics such as temporal location and eccentric tumor cysts distinguish GSC from Glioblastoma (GBM). The diagnosis of GSC was associated with a poorer survival outcome, potentially due to different genetic alterations in GSC compared to GBM. Prospective studies are needed to further understand the unique characteristics of GSC and develop targeted treatment approaches.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Oncology

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller et al.

Summary: The European Association of Neuro-Oncology (EANO) has released guidelines for the diagnosis, treatment, and follow-up of adult patients with diffuse gliomas, incorporating major changes in diagnostic algorithms based on the 2016 update of the WHO Classification of Tumors of the Central Nervous System, as well as evidence from recent large clinical trials.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Clinical Neurology

Primary and secondary gliosarcoma: differences in treatment and outcome

Bujung Hong et al.

Summary: The study aimed to compare the outcome and survival of patients with primary and secondary gliosarcoma following surgical resection and adjuvant treatment. Results showed that patients with primary gliosarcoma had higher progression-free survival and median overall survival compared to those with secondary gliosarcoma, while outcomes of patients with primary or secondary gliosarcoma were comparable to that of patients with primary or secondary GBM.

BRITISH JOURNAL OF NEUROSURGERY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Multidisciplinary Sciences

Genomic landscape of gliosarcoma: distinguishing features and targetable alterations

Mark M. Zaki et al.

Summary: Gliosarcoma is an aggressive brain tumor with histologic features of glioblastoma and soft tissue sarcoma. A study using a multi-center database identified 19 common genes in gliosarcoma, some of which overlap with GBM and soft tissue sarcoma while others are distinct, including potential therapeutic targets like BRAF, EGFR, CDKN2A, NF1, and PTEN. This unique genomic landscape may impact disease classification and clinical trial criteria.

SCIENTIFIC REPORTS (2021)

Review Oncology

Central Nervous System Cancers Version 3.2020

Louis Burt Nabors et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Medicine, General & Internal

Early Pulmonary Metastasis After a Surgical Resection of Glioblastoma Multiforme. A Case Report

Killen H. Briones-Claudett et al.

AMERICAN JOURNAL OF CASE REPORTS (2020)

Article Clinical Neurology

Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted

Takayuki Yasuda et al.

NEUROPATHOLOGY (2018)

Article Clinical Neurology

Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database

Jonathan Frandsen et al.

JOURNAL OF NEUROSURGERY (2018)

Article Oncology

Impact of treatment on survival of patients with secondary glioblastoma

Christina Hamisch et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Review Oncology

Extracranial metastases of high-grade glioma: the clinical characteristics and mechanism

Qian Sun et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)

Article Oncology

Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series

J. Castelli et al.

JOURNAL OF NEURO-ONCOLOGY (2016)

Article Oncology

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics

David Cachia et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

Article Clinical Neurology

Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy

Omprakash Damodaran et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2014)

Article Clinical Neurology

A Nonradiated Grade II Glioma That Underwent Delayed Malignant Transformation to a Gliosarcoma with Meningeal Growth and Dissemination

Fabien Rech et al.

JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY (2014)

Article

Secondary Gliosarcoma Arising From an Anaplastic Astrocytoma

Huanjiang Niu et al.

NEUROSURGERY QUARTERLY (2013)

Article Clinical Neurology

The impact of improved treatment strategies on overall survival in glioblastoma patients

P. J. Slotty et al.

ACTA NEUROCHIRURGICA (2013)

Review Clinical Neurology

Secondary gliosarcoma with extra-cranial metastases: A report and review of the literature

Richa Dawar et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2013)

Article Clinical Neurology

Gliosarcoma arising from an oligodendroglioma (oligosarcoma)

Annie Hiniker et al.

CLINICAL NEUROPATHOLOGY (2013)

Article Oncology

Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice

Gary V. Walker et al.

JOURNAL OF NEURO-ONCOLOGY (2013)

Article Clinical Neurology

Diagnostic utility of IDH1-and p53-mutation analysis in secondary gliosarcoma

B. F. M. Romeike et al.

CLINICAL NEUROPATHOLOGY (2011)

Article Oncology

The natural history of extracranial metastasis from glioblastoma multiforme

Melody Lun et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Review Oncology

Gliosarcoma with multiple extracranial metastases: case report and review of the literature

Thomas L. Beaumont et al.

JOURNAL OF NEURO-ONCOLOGY (2007)

Article Oncology

Gliosarcoma: a clinical study

J Lutterbach et al.

RADIOTHERAPY AND ONCOLOGY (2001)